BMPR2 and pulmonary arterial hypertension: Chowdhury et al. [17] demonstrated that the deficiency of bone morphogenetic protein receptor type II caused cell‐specific effects, including increasing the expression of Bcl‐XL transcripts in PASMCs while inhibiting it in ECs in PAH.